ENTA

NASDAQStock

Enanta Pharmaceuticals, Inc.

$13.06-0.34 (-2.57%)

52-Week Range

$4.26

$16.85

Key Stats

Market Cap

303.3M

P/E Ratio

—

Dividend Yield

—

Beta

0.97

Volume

155.5K

Avg Volume

180.2K

Performance

-3.11%

-9.82%

+79.76%

YTD

-7.00%

+101.65%

-69.87%

-74.38%

Price Chart

ETF Exposure

ENTA is held by 65 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	8	$107	$80.3M	0.10%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	13	$183	$80.4M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	15	$210	$63.0M	0.11%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	18	$249	$57.9M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	15	$207	$42.1M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	10	$137	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	7	$103	$21.0M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	3	$46	$9.3M	0.12%
IWV	iShares Russell 3000 ETF	0.00%	4,859	$69K	$17.30B	0.20%
SCHB	Schwab U.S. Broad Market ETF	0.00%	10,879	$152K	$37.50B	0.03%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	41	$732	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	1,497	$26K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	7	$126	$337.7M	0.32%
XEQT.TO	iShares Core Equity ETF Portfolio	0.00%	45,700	$51K	$14.63B	0.20%
XUU.TO	iShares Core S&P U.S. Total Market Index ETF	0.00%	45,700	$15K	$3.91B	0.07%

PreviousPage 2 of 2

About ENTA ETF Exposure

Enanta Pharmaceuticals, Inc. (ENTA) is held by 65 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 303.3M, ENTA is a widely held institutional stock. The stock currently trades at $13.06. Investors can gain exposure to ENTA through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ENTA, sorted by portfolio weight.